Human parechovirus 1 utilizes integrins αvβ3 and αvβ1 as receptors

Kathy Triantafilou, Martha Triantafilou, Yoshikazu Takada, Nelson Fernandez

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Human parechovirus 1 (HPEV1) displays an arginine-glycine-aspartic acid (RGD) motif in the VP1 capsid protein, suggesting integrins as candidate receptors for HPEV1. A panel of monoclonal antibodies (MAbs) specific for integrins αvβ3, αvβ1, and αvβ5, which have the ability to recognize the RGD motif, and also a MAb specific for integrin α2β1, an integrin that does not recognize the RGD motif, were tested on A549 cells. Our results showed that integrin αv-specific MAb reduced infectivity by 85%. To specify which αv integrins the virus utilizes, we tested MAbs specific to integrins αvβ3 and αcβv1 which reduced infectivity significantly, while a MAb specific for integrin αvβ5, as well as the MAb specific for α2β1, showed no reduction. When a combination of MAbs specific for integrins αvβ3 and αvβ1 were used, virus infectivity was almost completely inhibited; this shows that integrins αvβ3 and αvβ1 are utilized by the virus. We therefore proceeded to test whether αv integrins' natural ligands fibronectin and vitronectin had an effect on HPEV1 infectivity. We found that vitronectin reduced significantly HPEV1 infectivity, whereas a combination of vitronectin and fibronectin abolished infection. To verify the use of integrins αvβ3 and αvβ1 as HPEV1 receptors, CHO cells transfected and expressing either integrin αvβ3 or integrin αvβ1 were used. It was shown that the virus could successfully infect these cells. However, in immunoprecipitation experiments using HPEV1 virions and allowing the virus to bind to solubilized A549 cell extract, we isolated and confirmed by Western blotting the αvβ3 heterodimer. In conclusion, we found that HPEV1 utilises both integrin αvβ3 and αvβ1 as receptors; however, in cells that express both integrins, HPEV1 may preferentially bind integrin αvβ3.

Original languageEnglish
Pages (from-to)5856-5862
Number of pages7
JournalJournal of Virology
Volume74
Issue number13
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Human parechovirus
Parechovirus
Vasopressin Receptors
integrins
Integrins
receptors
Vitronectin
pathogenicity
Viruses
viruses
monoclonal antibodies
fibronectins
Monoclonal Antibodies
Fibronectins
cells

ASJC Scopus subject areas

  • Immunology

Cite this

Triantafilou, K., Triantafilou, M., Takada, Y., & Fernandez, N. (2000). Human parechovirus 1 utilizes integrins αvβ3 and αvβ1 as receptors. Journal of Virology, 74(13), 5856-5862. https://doi.org/10.1128/JVI.74.13.5856-5862.2000

Human parechovirus 1 utilizes integrins αvβ3 and αvβ1 as receptors. / Triantafilou, Kathy; Triantafilou, Martha; Takada, Yoshikazu; Fernandez, Nelson.

In: Journal of Virology, Vol. 74, No. 13, 2000, p. 5856-5862.

Research output: Contribution to journalArticle

Triantafilou, K, Triantafilou, M, Takada, Y & Fernandez, N 2000, 'Human parechovirus 1 utilizes integrins αvβ3 and αvβ1 as receptors', Journal of Virology, vol. 74, no. 13, pp. 5856-5862. https://doi.org/10.1128/JVI.74.13.5856-5862.2000
Triantafilou, Kathy ; Triantafilou, Martha ; Takada, Yoshikazu ; Fernandez, Nelson. / Human parechovirus 1 utilizes integrins αvβ3 and αvβ1 as receptors. In: Journal of Virology. 2000 ; Vol. 74, No. 13. pp. 5856-5862.
@article{71aeaaae91364d6782c277b5895b9e70,
title = "Human parechovirus 1 utilizes integrins αvβ3 and αvβ1 as receptors",
abstract = "Human parechovirus 1 (HPEV1) displays an arginine-glycine-aspartic acid (RGD) motif in the VP1 capsid protein, suggesting integrins as candidate receptors for HPEV1. A panel of monoclonal antibodies (MAbs) specific for integrins αvβ3, αvβ1, and αvβ5, which have the ability to recognize the RGD motif, and also a MAb specific for integrin α2β1, an integrin that does not recognize the RGD motif, were tested on A549 cells. Our results showed that integrin αv-specific MAb reduced infectivity by 85{\%}. To specify which αv integrins the virus utilizes, we tested MAbs specific to integrins αvβ3 and αcβv1 which reduced infectivity significantly, while a MAb specific for integrin αvβ5, as well as the MAb specific for α2β1, showed no reduction. When a combination of MAbs specific for integrins αvβ3 and αvβ1 were used, virus infectivity was almost completely inhibited; this shows that integrins αvβ3 and αvβ1 are utilized by the virus. We therefore proceeded to test whether αv integrins' natural ligands fibronectin and vitronectin had an effect on HPEV1 infectivity. We found that vitronectin reduced significantly HPEV1 infectivity, whereas a combination of vitronectin and fibronectin abolished infection. To verify the use of integrins αvβ3 and αvβ1 as HPEV1 receptors, CHO cells transfected and expressing either integrin αvβ3 or integrin αvβ1 were used. It was shown that the virus could successfully infect these cells. However, in immunoprecipitation experiments using HPEV1 virions and allowing the virus to bind to solubilized A549 cell extract, we isolated and confirmed by Western blotting the αvβ3 heterodimer. In conclusion, we found that HPEV1 utilises both integrin αvβ3 and αvβ1 as receptors; however, in cells that express both integrins, HPEV1 may preferentially bind integrin αvβ3.",
author = "Kathy Triantafilou and Martha Triantafilou and Yoshikazu Takada and Nelson Fernandez",
year = "2000",
doi = "10.1128/JVI.74.13.5856-5862.2000",
language = "English",
volume = "74",
pages = "5856--5862",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "13",

}

TY - JOUR

T1 - Human parechovirus 1 utilizes integrins αvβ3 and αvβ1 as receptors

AU - Triantafilou, Kathy

AU - Triantafilou, Martha

AU - Takada, Yoshikazu

AU - Fernandez, Nelson

PY - 2000

Y1 - 2000

N2 - Human parechovirus 1 (HPEV1) displays an arginine-glycine-aspartic acid (RGD) motif in the VP1 capsid protein, suggesting integrins as candidate receptors for HPEV1. A panel of monoclonal antibodies (MAbs) specific for integrins αvβ3, αvβ1, and αvβ5, which have the ability to recognize the RGD motif, and also a MAb specific for integrin α2β1, an integrin that does not recognize the RGD motif, were tested on A549 cells. Our results showed that integrin αv-specific MAb reduced infectivity by 85%. To specify which αv integrins the virus utilizes, we tested MAbs specific to integrins αvβ3 and αcβv1 which reduced infectivity significantly, while a MAb specific for integrin αvβ5, as well as the MAb specific for α2β1, showed no reduction. When a combination of MAbs specific for integrins αvβ3 and αvβ1 were used, virus infectivity was almost completely inhibited; this shows that integrins αvβ3 and αvβ1 are utilized by the virus. We therefore proceeded to test whether αv integrins' natural ligands fibronectin and vitronectin had an effect on HPEV1 infectivity. We found that vitronectin reduced significantly HPEV1 infectivity, whereas a combination of vitronectin and fibronectin abolished infection. To verify the use of integrins αvβ3 and αvβ1 as HPEV1 receptors, CHO cells transfected and expressing either integrin αvβ3 or integrin αvβ1 were used. It was shown that the virus could successfully infect these cells. However, in immunoprecipitation experiments using HPEV1 virions and allowing the virus to bind to solubilized A549 cell extract, we isolated and confirmed by Western blotting the αvβ3 heterodimer. In conclusion, we found that HPEV1 utilises both integrin αvβ3 and αvβ1 as receptors; however, in cells that express both integrins, HPEV1 may preferentially bind integrin αvβ3.

AB - Human parechovirus 1 (HPEV1) displays an arginine-glycine-aspartic acid (RGD) motif in the VP1 capsid protein, suggesting integrins as candidate receptors for HPEV1. A panel of monoclonal antibodies (MAbs) specific for integrins αvβ3, αvβ1, and αvβ5, which have the ability to recognize the RGD motif, and also a MAb specific for integrin α2β1, an integrin that does not recognize the RGD motif, were tested on A549 cells. Our results showed that integrin αv-specific MAb reduced infectivity by 85%. To specify which αv integrins the virus utilizes, we tested MAbs specific to integrins αvβ3 and αcβv1 which reduced infectivity significantly, while a MAb specific for integrin αvβ5, as well as the MAb specific for α2β1, showed no reduction. When a combination of MAbs specific for integrins αvβ3 and αvβ1 were used, virus infectivity was almost completely inhibited; this shows that integrins αvβ3 and αvβ1 are utilized by the virus. We therefore proceeded to test whether αv integrins' natural ligands fibronectin and vitronectin had an effect on HPEV1 infectivity. We found that vitronectin reduced significantly HPEV1 infectivity, whereas a combination of vitronectin and fibronectin abolished infection. To verify the use of integrins αvβ3 and αvβ1 as HPEV1 receptors, CHO cells transfected and expressing either integrin αvβ3 or integrin αvβ1 were used. It was shown that the virus could successfully infect these cells. However, in immunoprecipitation experiments using HPEV1 virions and allowing the virus to bind to solubilized A549 cell extract, we isolated and confirmed by Western blotting the αvβ3 heterodimer. In conclusion, we found that HPEV1 utilises both integrin αvβ3 and αvβ1 as receptors; however, in cells that express both integrins, HPEV1 may preferentially bind integrin αvβ3.

UR - http://www.scopus.com/inward/record.url?scp=0034045398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034045398&partnerID=8YFLogxK

U2 - 10.1128/JVI.74.13.5856-5862.2000

DO - 10.1128/JVI.74.13.5856-5862.2000

M3 - Article

C2 - 10846065

AN - SCOPUS:0034045398

VL - 74

SP - 5856

EP - 5862

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 13

ER -